MTSLead source
SITUATION DETECTED: Isomorphic Labs, Demis Hassabis’s AI drug-discovery spinout from Google DeepMind, is in early talks to raise at a valuation of at least $40 billion, and possibly $50 billion, per Bloomberg.Read original on X
StoryFirst seen
Isomorphic Labs in talks to raise at a $40 billion valuation
Demis Hassabis's AI drug-discovery spinout from Google DeepMind could command as much as $50 billion, per Bloomberg.
Archived Updated
Everything it touches
2 names 1 voices 1 source posts
The story’s neighborhood
NAMESVOICESPOSTS
Explore the graph, or choose a connection below.
Follow the evidence
The source posts
This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.
How the headline evolved
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs in talks to raise at a $40 billion valuation
Isomorphic Labs seeks $40 billion valuation in funding talks
Shared connections
Related stories
ElorianAI launches Glimpse vision model for spatial reasoning
Early side-by-side tests show the model, built by veterans of Google and Apple vision work, outscoring a rival on spatial tasks at low per-token prices.
Anthropic replaces git as agent-written code overwhelms merging
When agents merge code every few seconds, version control becomes the next bottleneck for engineering organizations everywhere.
Google rolls out Gemini Argon worldwide
A day-one global rollout across Google's products puts a new frontier model straight into consumer and enterprise hands.
Four Gemini agents beat Minecraft with no human help
The agents wrote thousands of programs, coordinated over chat, and debugged each other's errors across a 27-hour run, offering a concrete look at spontaneous agent teamwork.